Bilbolingo, Arnold K.
HRN: 22-70-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/13/2023
03/19/2023
IV
500mg
Q8
Acute Appendicitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes